CN110121353B - 用于维持和/或恢复健康皮肤微生物群的皮肤科制剂 - Google Patents

用于维持和/或恢复健康皮肤微生物群的皮肤科制剂 Download PDF

Info

Publication number
CN110121353B
CN110121353B CN201780050648.1A CN201780050648A CN110121353B CN 110121353 B CN110121353 B CN 110121353B CN 201780050648 A CN201780050648 A CN 201780050648A CN 110121353 B CN110121353 B CN 110121353B
Authority
CN
China
Prior art keywords
lactobacillus
skin
yun
plantarum
species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201780050648.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN110121353A (zh
Inventor
S·利比尔
I·卡拉斯
E·欧勒曼斯
M·范登布鲁克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yun Nv
Universiteit Antwerpen
Original Assignee
Yun Nv
Universiteit Antwerpen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yun Nv, Universiteit Antwerpen filed Critical Yun Nv
Publication of CN110121353A publication Critical patent/CN110121353A/zh
Application granted granted Critical
Publication of CN110121353B publication Critical patent/CN110121353B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
CN201780050648.1A 2016-06-21 2017-06-20 用于维持和/或恢复健康皮肤微生物群的皮肤科制剂 Active CN110121353B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE20165454A BE1024425B9 (nl) 2016-06-21 2016-06-21 Dermatologische preparaten voor het onderhouden en/of herstellen van een gezonde huidmicrobiota
BE2016/5454 2016-06-21
PCT/EP2017/065006 WO2017220525A1 (en) 2016-06-21 2017-06-20 Dermatological preparations for maintaining and/or restoring healthy skin microbiota

Publications (2)

Publication Number Publication Date
CN110121353A CN110121353A (zh) 2019-08-13
CN110121353B true CN110121353B (zh) 2024-03-12

Family

ID=57042630

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780050648.1A Active CN110121353B (zh) 2016-06-21 2017-06-20 用于维持和/或恢复健康皮肤微生物群的皮肤科制剂

Country Status (9)

Country Link
US (3) US20190344100A1 (enExample)
EP (1) EP3471836B1 (enExample)
JP (1) JP7153569B2 (enExample)
CN (1) CN110121353B (enExample)
BE (1) BE1024425B9 (enExample)
CA (1) CA3027458A1 (enExample)
ES (1) ES2985966T3 (enExample)
PL (1) PL3471836T3 (enExample)
WO (1) WO2017220525A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109715179A (zh) 2016-04-21 2019-05-03 内科德生物群系公司 用于治疗皮肤病症的组合物和方法
EP3666341B1 (en) 2018-12-14 2022-03-23 DWI - Leibniz-Institut für Interaktive Materialien e.V. Topical formulation in form of a patch, a bandage or a plaster comprising probiotic bacteria, and use thereof in a method for treating or preventing skin disorders
WO2020098988A1 (en) 2019-01-04 2020-05-22 Lactobio Aps Strains, composition and method of use
EP3914135A1 (en) * 2019-01-24 2021-12-01 TWE Meulebeke Dry nonwoven antibacterial article
CN114040770B (zh) * 2019-05-20 2025-02-28 莱雅公司 用于治疗、缓和或预防痤疮的组合物
CN110507598A (zh) * 2019-09-10 2019-11-29 河北一然生物科技有限公司 乳酸菌在抑制痤疮丙酸杆菌中的应用及用其制成的护肤品
US20220265545A1 (en) * 2020-02-13 2022-08-25 Cj Cheiljedang Corporation Composition for improving skin condition
CN112656838B (zh) * 2020-12-31 2022-04-15 广东丸美生物技术股份有限公司 一种药物组合物、其制备方法及应用
KR102297406B1 (ko) * 2021-01-22 2021-09-07 주식회사 커스토젠 피부상재 미생물 조절용 조성물
EP4245290A1 (en) * 2022-03-18 2023-09-20 JACH INVEST Janusz Chelchowski Cosmetic mask with saponite clay
CN114657106B (zh) * 2022-04-21 2023-11-21 青岛蔚蓝生物股份有限公司 一株植物乳植杆菌及其在防治痤疮中的应用
CN114657107B (zh) * 2022-04-21 2023-11-17 青岛蔚蓝生物股份有限公司 一株具有治疗痤疮作用的植物乳植杆菌及其应用
CN116004464B (zh) * 2023-01-06 2025-02-07 上海上药信谊药厂有限公司 一株植物乳杆菌及其应用
CN118325798B (zh) * 2024-06-17 2024-08-30 青岛诺和诺康生物科技有限公司 一株减少头皮屑及毛囊炎的鼠李糖乳酪杆菌nhnk-604及其制品和应用
CN119307410A (zh) * 2024-10-21 2025-01-14 湖南师范大学 一株植物乳杆菌及其应用

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001013956A2 (en) * 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
CN1568365A (zh) * 2001-10-12 2005-01-19 雷丁大学 包含戊糖乳杆菌菌株的组合物及其用途
CN1984665A (zh) * 2004-05-28 2007-06-20 三得利株式会社 具有免疫调节作用的组合物
CN101163788A (zh) * 2005-03-29 2008-04-16 布利斯技术有限公司 皮肤治疗组合物
CN101173228A (zh) * 2006-11-01 2008-05-07 信谊药厂 新的乳酸杆菌菌株、药物组合物及其用途、以及制造方法
KR20120089530A (ko) * 2010-12-21 2012-08-13 한국생명공학연구원 락토바실러스 플란타룸(Ｌａｃｔｏｂａｃｉｌｌｕｓ ｐｌａｎｔａｒｕｍ) ＳＹ99 및 이의 용도
CN103502434A (zh) * 2011-05-06 2014-01-08 有机平衡医疗股份公司 新型乳酸菌以及含有该乳酸菌的组合物
KR20150075447A (ko) * 2013-12-26 2015-07-06 (주)정가진면역연구소 여성 자궁 질염 예방 및 개선 기능성 조성물
WO2015140299A1 (en) * 2014-03-20 2015-09-24 Universiteit Antwerpen Oronasopharyngeal probiotics

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1736537A1 (en) * 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
JP5199551B2 (ja) * 2006-07-06 2013-05-15 サンスター株式会社 カンジダ菌感染に基づく疾患の予防又は改善剤
WO2010013182A1 (en) * 2008-07-29 2010-02-04 L'oreal Cosmetic use of microorganism(s) for the treatment of scalp disorders
KR101178217B1 (ko) * 2009-10-28 2012-09-07 씨제이제일제당 (주) 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
FR2953407B1 (fr) * 2009-12-08 2013-06-14 Oreal Microorganismes probiotiques a titre d'actif contre les alterations du microrelief
GB201206599D0 (en) 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
WO2013188626A2 (en) * 2012-06-15 2013-12-19 Dow Global Technologies Llc Probiotic-containing particles having improved probiotic stability when in aqueous formulations
US8906668B2 (en) * 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
FR2999601B1 (fr) 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
TWI643626B (zh) * 2013-08-12 2018-12-11 西班牙商巨妮亞實驗室有限公司 作為益生菌之乳桿菌屬菌株
JP6475475B2 (ja) * 2013-11-14 2019-02-27 株式会社ヤクルト本社 コラーゲン産生促進剤
CN106573023A (zh) * 2014-08-13 2017-04-19 雀巢产品技术援助有限公司 植物乳杆菌cncm i‑4026制备物及其皮肤健康益处

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001013956A2 (en) * 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
CN1568365A (zh) * 2001-10-12 2005-01-19 雷丁大学 包含戊糖乳杆菌菌株的组合物及其用途
CN1984665A (zh) * 2004-05-28 2007-06-20 三得利株式会社 具有免疫调节作用的组合物
CN101163788A (zh) * 2005-03-29 2008-04-16 布利斯技术有限公司 皮肤治疗组合物
CN101173228A (zh) * 2006-11-01 2008-05-07 信谊药厂 新的乳酸杆菌菌株、药物组合物及其用途、以及制造方法
KR20120089530A (ko) * 2010-12-21 2012-08-13 한국생명공학연구원 락토바실러스 플란타룸(Ｌａｃｔｏｂａｃｉｌｌｕｓ ｐｌａｎｔａｒｕｍ) ＳＹ99 및 이의 용도
CN103502434A (zh) * 2011-05-06 2014-01-08 有机平衡医疗股份公司 新型乳酸菌以及含有该乳酸菌的组合物
KR20150075447A (ko) * 2013-12-26 2015-07-06 (주)정가진면역연구소 여성 자궁 질염 예방 및 개선 기능성 조성물
WO2015140299A1 (en) * 2014-03-20 2015-09-24 Universiteit Antwerpen Oronasopharyngeal probiotics

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Selective targeting of skin pathobionts and inflammation with topically applied lactobacilli;Sarah Lebeer等;《Cell Rep Med》;20220215;第3卷(第2期);全文 *
The innovative potential of Lactobacillus rhamnosus LR06, Lactobacillus pentosus LPS01, Lactobacillus plantarum LP01, and Lactobacillus delbrueckii Subsp. delbrueckii LDD01 to restore the "gastric barrier effect" in patients chronically treated with PPI;Mario Del Piano等;《J Clin Gastroenterol》;20121031;第46卷(第pS18-26期);全文 *
乳酸杆菌临床应用的研究进展;周敏等;《中国微生态学杂志》;20091231;第21卷(第12期);全文 *

Also Published As

Publication number Publication date
CN110121353A (zh) 2019-08-13
EP3471836C0 (en) 2024-05-22
BE1024425B9 (nl) 2018-03-26
BE1024425B1 (nl) 2018-02-20
WO2017220525A1 (en) 2017-12-28
ES2985966T3 (es) 2024-11-08
CA3027458A1 (en) 2017-12-28
EP3471836A1 (en) 2019-04-24
EP3471836B1 (en) 2024-05-22
JP2019522649A (ja) 2019-08-15
US20190344100A1 (en) 2019-11-14
BE1024425A9 (nl) 2018-03-20
BE1024425A1 (nl) 2018-02-14
PL3471836T3 (pl) 2024-09-30
US20250302733A1 (en) 2025-10-02
JP7153569B2 (ja) 2022-10-14
US20210361978A1 (en) 2021-11-25

Similar Documents

Publication Publication Date Title
CN110121353B (zh) 用于维持和/或恢复健康皮肤微生物群的皮肤科制剂
Mezzasalma et al. Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study
US11000558B2 (en) Vaginal preparations for maintaining and/or restoring healthy female microbiota
US9585922B2 (en) Lactic acid bacteria that co-aggregate with pathogenic bacteria
Nowrouzian et al. Escherichia coli strains with the capacity for long-term persistence in the bowel microbiota carry the potentially genotoxic pks island
US8529892B2 (en) Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions
US12036254B2 (en) Bacterial strains of the Lactobacillus paracasei species for use, oral or topical, in the treatment of disorders of the female urogenital tract
CN114127258A (zh) 两歧双歧杆菌细菌菌株、其组合物和相关应用
CN109715179A (zh) 用于治疗皮肤病症的组合物和方法
CN104508117A (zh) 新的卷曲乳杆菌菌株
CA3128357A1 (en) Pharmaceutical composition for prevention, amelioration, or treatment of skin disease
HK40010465B (zh) 用於维持和/或恢复健康皮肤微生物群的皮肤科制剂
HK40010465A (en) Dermatological preparations for maintaining and/or restoring healthy skin microbiota
HK40002356B (en) Vaginal preparations for maintaining and/or restoring healthy female microbiota
HK40002356A (en) Vaginal preparations for maintaining and/or restoring healthy female microbiota
CN119530074A (zh) 一种格氏乳杆菌m17c及其组合物
CN119530073A (zh) 一种卷曲乳杆菌x25b及其用途
Reid PROBIOTICS AND HEALTH
HK1207116B (en) Novel strain of lactobacillus crispatus

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40010465

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant